Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.

Cerebral spinal fluid (CSF) Aβ42, tau and p181tau are widely accepted biomarkers of Alzheimer's disease (AD). Numerous studies show that CSF tau and p181tau levels are elevated in mild-to-moderate AD compared to age-matched controls. In addition, these increases might predict preclinical AD in...

Full description

Bibliographic Details
Main Authors: Jere E Meredith, Sethu Sankaranarayanan, Valerie Guss, Anthony J Lanzetti, Flora Berisha, Robert J Neely, J Randall Slemmon, Erik Portelius, Henrik Zetterberg, Kaj Blennow, Holly Soares, Michael Ahlijanian, Charles F Albright
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3792042?pdf=render

Internet

http://europepmc.org/articles/PMC3792042?pdf=render

Similar Items